financetom
Business
financetom
/
Business
/
Blackstone Closes $750 Million Debt Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone Closes $750 Million Debt Offering
Dec 6, 2024 1:54 PM

04:35 PM EST, 12/06/2024 (MT Newswires) -- Blackstone (BX) said late Friday its indirect subsidiary, Blackstone Reg Finance, completed a $750 million offering of 5% senior notes due 2034.

Proceeds from the offering will be used for general corporate purposes, according to the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Shift4 Further Extends Previously Announced Tender Offer To Acquire Global Blue
BRIEF-Shift4 Further Extends Previously Announced Tender Offer To Acquire Global Blue
May 26, 2025
May 21 (Reuters) - Shift4 Payments Inc ( FOUR ): * SHIFT4 FURTHER EXTENDS PREVIOUSLY ANNOUNCED TENDER OFFER TO ACQUIRE GLOBAL BLUE Source text: Further company coverage: ...
NeurAxis Launches $5 Million Direct Offering
NeurAxis Launches $5 Million Direct Offering
May 26, 2025
07:57 AM EDT, 05/21/2025 (MT Newswires) -- NeurAxis (NRXS) said Wednesday that it has launched a registered direct offering for the purchase and sale of 1.5 million shares at $3.25 per share for gross proceeds of $5 million. The offering is expected to close on or about Thursday. NeurAxis said the net proceeds will be used for working capital and...
Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer
Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer
May 26, 2025
07:59 AM EDT, 05/21/2025 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Wednesday that the first patient has been dosed in its phase 1/2 trial to treat patients with methylthioadenosine phosphorylase-deleted solid tumors, with a focus on glioblastoma. TNG456 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor, the company said. People with GBM currently have few treatment options and a five-year...
Shift4 Payments Further Extends Tender Offer to Acquire Global Blue
Shift4 Payments Further Extends Tender Offer to Acquire Global Blue
May 26, 2025
07:59 AM EDT, 05/21/2025 (MT Newswires) -- Shift4 Payments ( FOUR ) said Wednesday it has again extended its all-cash tender offer for all of the outstanding shares of Global Blue Group Holding ( GB ) . Global Blue's ( GB ) board has recommended that all shareholders tender their shares into the offer, which will remain open through one...
Copyright 2023-2025 - www.financetom.com All Rights Reserved